Pharmaceutical Information |
Drug Name |
Diazoxide |
Drug ID |
BADD_D00649 |
Description |
A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. |
Indications and Usage |
Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma. |
Marketing Status |
approved |
ATC Code |
C02DA01; V03AH01 |
DrugBank ID |
DB01119
|
KEGG ID |
D00294
|
MeSH ID |
D003981
|
PubChem ID |
3019
|
TTD Drug ID |
D07WEP
|
NDC Product Code |
51552-1582; 58159-039; 51927-0297; 14501-0096; 0254-1010; 45562-1740; 69575-4025; 0575-6200; 38779-0324; 52952-003; 38779-3184; 51927-2742; 62991-2857; 71052-664; 13517-100 |
UNII |
O5CB12L4FN
|
Synonyms |
Diazoxide | Proglycem | Hyperstat |
|
Chemical Information |
Molecular Formula |
C8H7ClN2O2S |
CAS Registry Number |
364-98-7 |
SMILES |
CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|